Ridogrel
Alternative Names: R 68070Latest Information Update: 11 Sep 2002
At a glance
- Originator Janssen L.P.
- Class Anti-ischaemics; Antiplatelets; Pentanoic acids; Pyridines; Small molecules; Vascular disorder therapies
- Mechanism of Action Thromboxane A2 receptor antagonists; Thromboxane synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arterial thrombosis; Ischaemic heart disorders; Ulcerative colitis
Most Recent Events
- 20 May 2002 Discontinued - Phase-III for Ulcerative colitis in Belgium (PO)
- 20 May 2002 Discontinued - Phase-III for Ulcerative colitis in United Kingdom (PO)
- 20 May 2002 Discontinued - Phase-III for Ulcerative colitis in USA (PO)